Used in pharmaceutical research as a key scaffold in the development of kinase inhibitors, particularly targeting cyclin-dependent kinases (CDKs) involved in cell cycle regulation. Shows potential in anticancer drug design due to its ability to induce apoptosis and inhibit tumor cell proliferation. Also investigated for anti-inflammatory and antimicrobial properties, leveraging its benzimidazole core for interaction with biological targets. Employed in structure-activity relationship (SAR) studies to optimize potency and selectivity in drug candidates.